What is the diagnostic approach for granulosa cell tumors of the ovaries?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Approach for Granulosa Cell Tumors of the Ovaries

The diagnosis of ovarian granulosa cell tumors requires a comprehensive workup including pelvic ultrasound, abdomino-pelvic CT scan, chest X-ray, and PET scan in selected cases, along with specific tumor markers and histopathological confirmation by an expert pathologist. 1

Clinical Presentation

Granulosa cell tumors (GCTs) typically present with:

  • Subacute pelvic pain
  • Feeling of pelvic pressure due to pelvic mass
  • Menstrual irregularities 1
  • Postmenopausal bleeding (in older women) due to endometrial hyperplasia 1
  • Hormonal manifestations (estrogen excess) 1
  • Some patients (approximately 30%) may be asymptomatic 2

Diagnostic Algorithm

Step 1: Imaging Studies

  • Transvaginal and transabdominal ultrasound (first-line imaging)

    • Look for characteristic features:
      • Multilocular-solid masses (52%)
      • Purely solid masses (39%)
      • Large tumors (median diameter 102 mm)
      • Multiple small locules (>10) in multilocular tumors
      • Mixed or low-level echogenicity 2
      • Moderate to high vascularity on color Doppler (color score 3-4) 3, 2
  • Abdomino-pelvic CT scan - for better characterization and staging 1

  • Chest X-ray - to rule out metastatic disease 1

  • PET scan - in selected cases for evaluation of metastatic disease 1

Step 2: Laboratory Tests

  • Hormone levels:
    • Inhibin B - elevated in 80-90% of cases (key biomarker) 4
    • Estradiol - often elevated 5
  • Other tumor markers:
    • CA-125 (may be elevated but non-specific)
  • Complete blood count
  • Liver and renal function tests 1

Step 3: Endometrial Assessment

  • Endometrial curettage/biopsy - must be performed to rule out concomitant uterine cancers, as endometrial pathology is found in up to 54% of patients due to estrogen production by the tumor 1, 2

Step 4: Histopathological Confirmation

  • Surgical specimen - definitive diagnosis requires histopathological examination 1
  • Expert pathologist review - histological second opinion by an expert pathologist should always be considered 1

Histopathological Diagnosis

  • Adult form characteristics:

    • Small uniform cells with scanty cytoplasm
    • Grooved nuclei ("coffee bean" appearance)
    • Small eccentric nucleoli
    • Macrofollicular, microfollicular, solid, insular or trabecular patterns
    • Characteristic Call-Exner bodies 1
  • Immunohistochemistry panel:

    • Inhibin alpha (positive)
    • Calretinin (positive)
    • FOXL2 (positive)
    • CD99 and melan A (positive) 1
  • Molecular testing:

    • FOXL2 (402C-G) mutation analysis - useful to confirm diagnosis in morphologically ambiguous cases 1

Diagnostic Challenges and Pitfalls

  • GCTs can be misdiagnosed as benign or other cystic tumors, especially when presenting as pure cystic lesions 5
  • Juvenile GCTs (occurring in patients <20 years) may present differently with sexual precocity 1
  • Varying histopathological features can make diagnosis difficult, including tumor cells with luteinization or free cell clusters 5
  • Differential diagnosis includes other ovarian tumors, particularly endometrioid carcinoma or carcinoid tumors 1

Follow-up After Diagnosis

  • Regular follow-up with transvaginal ultrasound is essential for monitoring recurrence 3
  • Inhibin levels should be monitored to detect recurrence 6
  • Sonographic features of recurrences are comparable to those of primary tumors 3

Key Points to Remember

  • GCTs account for 2-8% of all ovarian malignancies 7
  • They are more difficult to diagnose than epithelial ovarian tumors 7
  • Most GCTs are unilateral and confined to the ovary at diagnosis 1
  • Bilateral presentation is rare, especially with pure cystic features 5
  • Tumor stage at diagnosis remains the most important prognostic factor 1

By following this diagnostic approach, clinicians can accurately identify granulosa cell tumors of the ovary and initiate appropriate treatment to improve patient outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Imaging of gynecological disease (3): clinical and ultrasound characteristics of granulosa cell tumors of the ovary.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 2008

Research

Transvaginal ultrasound in evaluation and follow-up of ovarian granulosa cell tumors.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2020

Guideline

Management of Ovarian Cancer

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of granulosa cell tumour of the ovary.

Current opinion in oncology, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.